While GLP-1 drugs were originally designed for diabetes and obesity, clinical data show they significantly reduce markers of inflammation (like C-reactive protein, or CRP) remarkably quickly, usually long before any significant weight loss occurs
However, current recommendations are 2-3 500 mg capsules or doses per day
Evaluate your research with RETATRUTIDE, a premium research product from Stratford Peptides, meticulously crafted for laboratory exploration innovation
Whether you have health insurance through your employer or buy it on the marketplace, there's a good chance you'll see some changes to your plan in 2026
Diabetes Care, 39 , 20652079
Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats